For DNase I treatment, a 1.5–2-fold decrease in the abundance of tumour-specific fragments of Myc, Hmga2 and Jun was observed, in the case of Hmga2 to the level of healthy mice, while the abundance of Fos was slightly increased (Table 4). This evidence concerns the gene FOS and neoplasm.